IMARC Group, a leading market research company, has recently releases report titled “Peripheral Artery Disease Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global peripheral artery disease market growth, share, size, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Peripheral Artery Disease (PAD) is a circulatory condition that occurs when there is a narrowing or blockage in the arteries that supply blood to the limbs, particularly the legs. It is caused by a buildup of plaque, which consists of cholesterol, fat, calcium, and other substances, on the inner walls of the arteries. This buildup restricts blood flow and oxygen supply to the muscles and tissues in the affected area, leading to symptoms such as leg pain, cramping, weakness, and difficulty walking. If left untreated, PAD can progress and increase the risk of serious complications, including non-healing wounds and infections, gangrene, and even limb amputation. Risk factors for PAD include smoking, diabetes, high blood pressure, high cholesterol, obesity, and a sedentary lifestyle. Early detection and management of PAD are crucial to prevent its progression and improve the patient’s quality of life. Treatment options may include lifestyle changes, medication, exercise therapy, and in severe cases, interventional procedures or surgery to restore blood flow to the affected arteries. Regular check-ups and maintaining a healthy lifestyle are essential to managing PAD effectively.
The global peripheral artery disease market size reached US$ 4.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.94% during 2023-2028.
The Peripheral Artery Disease (PAD) market is witnessing significant growth, driven by various industry trends and drivers. One of the primary factors contributing to market expansion is the increasing prevalence of PAD, especially in the aging population. As the global population ages, the incidence of PAD is rising, leading to a higher demand for effective diagnostic and treatment solutions. Advancements in medical technology and innovative treatment options are also boosting the PAD market. Improved imaging techniques, minimally invasive procedures, and novel drug therapies are enhancing patient outcomes and driving the adoption of PAD treatments. Moreover, the growing awareness about PAD and its risk factors among healthcare professionals and patients is encouraging early diagnosis and timely intervention. Early detection of PAD allows for better management and reduces the risk of complications, thereby positively impacting the market growth. In addition, the rising healthcare expenditure and increasing investments in research and development activities are fueling the development of new and more efficient PAD therapies. This has led to the introduction of novel drugs and medical devices, further propelling market growth.
The report has segmented the market into the following categories:
Breakup by Type:
Breakup by End User:
Breakup by Region:
Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Koninklijke Philips N.V., Medtronic plc and Terumo Corporation.
